---
category: disclosure
circular_id: 9237011956d5824c
date: '2026-02-02'
description: Companies provide clarifications on price movements and volume spikes,
  confirming compliance with SEBI LODR Regulations and stating movements are market-driven.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={110CE377-D39C-42DD-9571-8F85BAE0A98B}&noticeno=20260202-30&dt=02/02/2026&icount=30&totcount=43&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine clarifications confirming no material undisclosed information;
  price movements attributed to market forces with no operational impact
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20260202-30&attachedId=2d9430cd-e680-45ed-a581-3fbd31547e9d
processing:
  attempts: 1
  content_hash: 7ce3af4a30dc3e29
  processed_at: '2026-02-02T15:50:15.690485'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2026-02-02T13:21:31+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={110CE377-D39C-42DD-9571-8F85BAE0A98B}&noticeno=20260202-30&dt=02/02/2026&icount=30&totcount=43&flag=0
severity: low
source: bse
stocks:
- '544676'
- '532872'
- ITDC
- GALAPREC
tags:
- price-movement
- volume-spike
- clarification
- regulation-30
- surveillance
- market-driven
title: Clarifications received from the companies
---

## Summary

BSE sought clarifications from multiple companies regarding significant price movements and volume increases in their securities. Four companies - Yajur Fibres Ltd., Sun Pharma Advanced Research Company Ltd., India Tourism Development Corporation Ltd., and Gala Precision Engineering Ltd. - responded confirming compliance with SEBI LODR Regulations, stating they have made all required disclosures under Regulation 30, and are unaware of any specific reasons for the price/volume movements which they attribute to market forces.

## Key Points

- Yajur Fibres Ltd. (Scrip Code: 544676) clarified it is not aware of reasons for significant price movement and states management is not connected with share price movement
- Sun Pharma Advanced Research Company Ltd. (Scrip Symbol: 532872) confirmed compliance with Regulation 30 and stated no undisclosed information exists
- India Tourism Development Corporation Ltd. (ITDC) responded to queries about spurt in volume, confirming no pending disclosures under SEBI LODR Regulations 2015
- Gala Precision Engineering Ltd. provided clarification to BSE Surveillance Department
- All companies emphasized movements are purely market-driven
- All companies confirmed adherence to disclosure requirements under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

## Regulatory Changes

No regulatory changes introduced. This circular documents company responses to exchange surveillance queries as part of routine monitoring under existing SEBI LODR framework.

## Compliance Requirements

- Companies confirmed ongoing compliance with Regulation 30 of SEBI LODR Regulations 2015
- All material information affecting company operations/performance has been disclosed within stipulated timelines
- Companies committed to continue timely and adequate disclosures to stock exchanges
- No new compliance requirements imposed

## Important Dates

- February 02, 2026: Date of clarifications submitted by all four companies to BSE

## Impact Assessment

**Market Impact:** Minimal. These are routine surveillance clarifications confirming no undisclosed material events. The circular provides transparency that observed price/volume movements are market-driven rather than based on undisclosed material information.

**Investor Impact:** Low. Investors are informed that companies have no pending material disclosures and price movements reflect normal market dynamics.

**Operational Impact:** None. No operational changes required for listed entities beyond existing disclosure obligations.

**Compliance Impact:** Neutral. Demonstrates functioning of exchange surveillance mechanisms and company adherence to disclosure norms under Regulation 30.